Federal health officials have agreed to import a meningitis vaccine approved in Europe and Australia but not the U.S. as officials at Princeton University consider measures to stop the spread of the disease on the Ivy League campus. The Food and Drug Administration this week approved importing Bexsero for possible use on Princeton’s campus, said Barbara Reynolds, a spokeswoman for the Centers for Disease Control and Prevention. Princeton officials confirmed the school’s seventh case of meningitis in 2013 this week and a spokesman said trustees will discuss the issue this weekend. No vaccine for use against the type B meningococcal bacteria that caused the cases at Princeton is available in the U.S., Reynolds said, adding that the decision to receive the vaccine would be optional if Princeton and CDC officials agree to offer it to students. Bacterial meningitis can cause swelling of the membranes covering the brain and spinal cord. The disease is...
đź”’ Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




